Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. lung cancer foundation and the joan gaeta lung cancer
Show results for

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Brands

  • medchemexpress
  • spacegen
  • amoydx
  • elicio
  • panamutyper r
View all brands
Applications

  • Diagnostic Solutions for Lung Cancer
  • Liquid Biopsy Solutions for Breast Cancer
  • Diagnostic Solutions for Colorectal Cancer
  • microbiota for Clinical Studies
  • Robotic-Assisted Bronchoscopy System for Lung Cancer Statistics
  • Robotic-Assisted Bronchoscopy System for Lung Nodules
  • Clean air solutions for allergens area
  • Clean air solutions for pollution area
  • Clean air solutions for bad odor area
  • Clean air solutions for bacteria area
  • Clean air solutions for virus area
  • Radioactive Drugs for Diagnostics
  • Radioactive Drugs for Therapeutics

Lung Cancer Foundation And The Joan Gaeta Lung Cancer Equipment & Supplies

380 equipment items found

Menssana - Breath Test for Lung Cancer

Menssana - Breath Test for Lung Cancer

Manufactured by:Menssana Research Inc.   based inEdgewater, NEW JERSEY (USA)
Every year in the U.S.A., 99,000 men and 78,000 women develop lung cancer, and only 14% of them are still alive five years later. Fortunately, early detection and treatment can reduce the number of deaths. Clinical studies at Menssana Research, Inc. have shown that breath biomarkers accurately identify lung cancer, and this has been confirmed in a blinded replicated ...
CONTACT SUPPLIER

KRAS G12C inhibitor 61

KRAS G12C inhibitor 61

by:Alfa Cytology   based inU.S. VIRGIN ISLANDS
KRAS G12C inhibitor 61 inhibits phosphorylated ERK 1/2 in MIA PaCa-2 cells with an IC50 of 9 nM. KRAS G12C inhibitor 61 may be used in studies of pancreatic, colorectal, and lung cancers. ...
CONTACT SUPPLIER

Taiho - Model TAS6417 - Tyrosine Kinase Inhibitor

Taiho - Model TAS6417 - Tyrosine Kinase Inhibitor

Manufactured by:Taiho Oncology, Inc.   based inPrinceton, NEW JERSEY (USA)
Tyrosine Kinase Inhibitor of EGFR exon 20 insertion mutations. Non-Small Cell Lung Cancer (Phase 1/2) PHASE ...
CONTACT SUPPLIER

Broncus - Model RF-II - Radiofrequency Ablation System

Broncus - Model RF-II - Radiofrequency Ablation System

Manufactured by:Broncus Medical, Inc.   based inSan Jose, CALIFORNIA (USA)
RF-II is a radiofrequency ablation system used in conjunction with a disposable lung radiofrequency ablation catheter, which acts on lung tumors via a bronchoscope to perform ablation to the lung tumors. It is currently the only RFA system that specifically focuses on lung cancer treatment globally, according to Frost & Sullivan. According to Frost & Sullivan, radiofrequency ablation is ...
CONTACT SUPPLIER

STEMA - Bronchoscopy Device

STEMA - Bronchoscopy Device

Manufactured by:STEMA Medizintechnik GmbH   based inNeuhausen ob Eck, GERMANY
Bronchoscopy is one of the most important examination methods for detection of diseases of the respiratory tract and lungs, especially if you suspect the presence of lung ...
CONTACT SUPPLIER

Vitro - Human Lung Adenocarcinoma Cancer Associated Fibroblasts: 1,000,000 Cells Per Vial

Vitro - Human Lung Adenocarcinoma Cancer Associated Fibroblasts: 1,000,000 Cells Per Vial

Manufactured by:Vitro Biopharma   based inGolden, COLORADO (USA)
Human Lung Adenocarcinoma Cancer Associated Fibroblasts; Cryopreserved at a low passage; Stage: III; High passage capabilities; Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability); Able to grow in low oxygen (1% - 5% O2); Available for research ...
CONTACT SUPPLIER

Futibatinib - Model FGFR 1-4 - Inhibitor

Futibatinib - Model FGFR 1-4 - Inhibitor

Manufactured by:Taiho Oncology, Inc.   based inPrinceton, NEW JERSEY (USA)
Tumors with specific FGFR aberrations: Solid tumors, Gastric cancer, Myelolymphoid neoplasms PHASE ...
CONTACT SUPPLIER

Boston - Model BOS172738 - ATP-Competitive RET (Rearranged during Transfection) Kinase Inhibitor

Boston - Model BOS172738 - ATP-Competitive RET (Rearranged during Transfection) Kinase Inhibitor

Manufactured by:Boston Pharmaceuticals   based inCambridge, MASSACHUSETTS (USA)
BOS172738 is a highly selective, reversible, ATP-competitive RET (Rearranged during Transfection) kinase inhibitor. RET rearrangements and activating mutations are found in multiple solid tumors, but especially with non-small cell lung cancers and medullary thyroid carcinomas. ...
CONTACT SUPPLIER

Santa Cruz Biotechnology, Inc. - Pheophorbide a

Santa Cruz Biotechnology, Inc. - Pheophorbide a

Manufactured by:Santa Cruz Biotechnology, Inc.   based inDallas, TEXAS (USA)
Pheophorbide a is a chlorophyll-related compound studied for its anti-tumor and anti-cancer ...
CONTACT SUPPLIER

Genmab Amivantamab - Human Bispecific Antibody

Genmab Amivantamab - Human Bispecific Antibody

by:Genmab A/S    based inCopenhagen V, DENMARK
Amivantamab is a fully human bispecific antibody that targets EGFR and Met, two validated cancer targets. In July 2012, Genmab entered into a collaboration with Janssen Biotech, Inc. to create and develop bispecific antibodies using Genmab’s DuoBody® technology platform. The two antibody libraries used to produce amivantamab were both generated by Genmab. The antibody pair used to ...
CONTACT SUPPLIER

ViennaLab StripAssay - Model EGFR XL - Gene Therapy

ViennaLab StripAssay - Model EGFR XL - Gene Therapy

Manufactured by:ViennaLab Diagnostics GmbH   based inVienna, AUSTRIA
NSCLC comprises approximately 85% of all lung cancers. Tumor specimens from patients should be tested for the presence of EGFR mutations prior to TKI treatment. The EGFR XL StripAssay® and EGFR T790M RealFast™ Assay are designed to assist clinicians in the stratification of patients considered for TKI ...
CONTACT SUPPLIER

OTraces - Model BC Sera Dx - Immunoassay Test Kit

OTraces - Model BC Sera Dx - Immunoassay Test Kit

Manufactured by:OTraces Inc.   based inSykesville, MARYLAND (USA)
BC Sera Dx Immunoassay test panel for detection of the presence of breast cancer in women. In the development pipeline are an Ovarian, OV Sera Dx, and Lung, LG Sera Dx, cancer detection test ...
CONTACT SUPPLIER

Monarch - Robotic-Assisted Bronchoscopy System

Monarch - Robotic-Assisted Bronchoscopy System

Manufactured by:Auris Health, Inc.   based inRedwood City, CALIFORNIA (USA)
If your physician has discovered a spot on your lung, often called a small mass or nodule, you may need to have it tested to find out what it is. This is called a lung biopsy. Although most lung nodules are not cancer, it is important to find out what it is. There are a few options available for reaching small nodules in the lung. These small masses can be very difficult to reach with manual ...
CONTACT SUPPLIER

AI-Powered Cancer Detection

AI-Powered Cancer Detection

by:VisionGate, Inc   based inPhoenix, ARIZONA (USA)
Smart, Accurate, & Dynamic. Our AI Learns about Your Cells Fast. In addition to three dimensional images of your cells, our technology has the ability to learn and adapt to discover which cells should raise a red flag of warning and which are completely normal in your ...
CONTACT SUPPLIER

BreathBase - Data-Driven Medicine

BreathBase - Data-Driven Medicine

Manufactured by:Breathomix   based inLeiden, NETHERLANDS
Generally speaking, integrated databases contain information collected from more than one data source. Combining data from multiple sources yields increased statistical power to identify important relationships between data elements. Integrated databases are commonly being used by research institutes, pharmaceutical companies, and regulatory agencies. The digital transformation of healthcare ...
CONTACT SUPPLIER

Starpharma - DEP® irinotecan (Phase 2)

Starpharma - DEP® irinotecan (Phase 2)

by:Starpharma Holdings Limited   based inMelbourne, AUSTRALIA
DEP® irinotecan is an improved version of irinotecan (Camptosar®), predominantly used for colorectal cancer. DEP® irinotecan is a novel, patented nanoparticle formulation of SN-38, the active metabolite of irinotecan, delivered using Starpharma’s proprietary DEP® technology. Irinotecan (Camptosar®) is a major cancer drug used to treat colorectal cancer with peak global ...
CONTACT SUPPLIER

Trans-Capsaicin

Trans-Capsaicin

Distributed by:Aversion Technologies, Inc   based inBowie, MARYLAND (USA)
Trans-capsaicin is truly the 'gold-standard' for hotness. This highly refined product has few impurities and has been the preferred active for dermal patches and other medicinal uses. Many have reported that trans-capsaicin is more effective than the natural product or ...
CONTACT SUPPLIER

multimmune - Model mi-APO - Apoptosis-Inducing Enzyme

multimmune - Model mi-APO - Apoptosis-Inducing Enzyme

Manufactured by:multimmune GmbH   based inMunich, GERMANY
mi-APO is a targeted protein product with potential to be used for the treatment of most tumor types. The product targets surface-bound heat shock protein 70 (Hsp70). Surface-bound Hsp70 is a tumor-specific marker expressed on about 50-75% of various cancer entities, e.g. lung, colon, breast, pancreas. Application of mi-APO, a recombinant serine protease, results in a specific ...
CONTACT SUPPLIER

AMEGA Megavex - Model BETA-1A - Interferons

AMEGA Megavex - Model BETA-1A - Interferons

Manufactured by:AMEGA Biotech   based inOlivos, ARGENTINA
Interferons are a group of antiviral proteins produced in reaction to viral infections. It boosts the resistance of surrounding cells to attacks by viruses, inhibits viral multiplication and modifies the body’s response. Interferon beta is produced by fibroblasts. It is used in the treatment of multiple sclerosis. Interferon beta-1a is a human recombinant glycoprotein expressed by Chinese ...
CONTACT SUPPLIER

CytomX - Model CX-2009 - CD166 - Probody Drug Conjugate (PDC)

CytomX - Model CX-2009 - CD166 - Probody Drug Conjugate (PDC)

Manufactured by:CytomX Therapeutics, Inc.   based inSouth San Francisco, CALIFORNIA (USA)
CytomX is developing CX-2009, a Probody drug conjugate (PDC) conjugated with DM4, a highly potent cytotoxic drug, targeting CD166, also known as ALCAM. CD166 is a molecule widely and highly expressed on solid tumor cells and previously considered “undruggable” given its expression on normal tissues. In preclinical studies, Probody drug conjugates targeting CD166, have led to ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT